CD27 antibody
Quick Overview for CD27 antibody (ABIN94051)
Target
See all CD27 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- Anti-Hu CD27 Purified
-
Specificity
- The antibody LT27 reacts with an extracellular epitope of CD27 (T14), a 50-55 kDa type I transmembrane glycoprotein (member of the TNF-receptor superfamily) expressed on medullary thymocytes, peripheral T lymphocytes, some B lymphocytes and NK cells.
-
Cross-Reactivity (Details)
- Human
-
Purification
- Purified by protein-A affinity chromatography.
-
Purity
- > 95 % (by SDS-PAGE)
-
Immunogen
- Human peripheral blood lymphocytes
-
Isotype
- IgG2a
-
-
-
-
Application Notes
- Flow cytometry: Recommended dilution: 2 μg/mL.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Do not freeze.
-
Storage
- 4 °C
-
Storage Comment
- Store at 2-8°C. Do not freeze.
-
-
- CD27 (CD27 Molecule (CD27))
-
Alternative Name
- CD27
-
Background
- CD27 Molecule,CD27 is a transmembrane 55 kDa protein of the nerve growth factor-receptor family, expressed as a disulfide-linked homodimer on mature thymocytes, peripheral blood T cells and a subpopulation of B cells. Activation of T cells via TCR-CD3 complex results in upregulation of CD27 expression on the plasma membrane as well as in the release of its soluble 28-32 kDa form, sCD27, detected in the plasma, urine or spinal fluid. This sCD27 is an important prognostic marker of acute and chronic B cell malignancies. RgpA, a cystein proteinase, although activating T cells through the protease-activated receptors (PARs), degradates CD27 and counteracts T cell activation mediated by CD27 and its ligand CD70.,T14, TNFRSF7, LPFS2, S152, Tp55
-
Gene ID
- 939
-
UniProt
- P26842
-
Pathways
- Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
Target
-